Indeed, expanded clones in tumours exhibiting a high TMB, such as melanoma, may be recognising tumour-derived peptides, but they might be inhibited by programmed cell death protein 1 (PD-1), or cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). This evidence concerns the gene CTLA4 and neoplasm.